PDL BioPharma, Inc. Operating Lease, Expense
PDL BioPharma, Inc. reported Operating Lease, Expense of $532.00 thousand for the 8-month period ending 2020-08-31, per its 10-K filed 2021-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2021-03-29
- PDL BioPharma, Inc. operating lease, expense for the quarter ending 2019-03-31 was $233.00K, a 18.25% decline year-over-year.
- PDL BioPharma, Inc. operating lease, expense for the quarter ending 2018-03-31 was $285.00K.
- PDL BioPharma, Inc. operating lease, expense for fiscal 2019 was $760.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 8 month | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|
| 2020-08-31 | $532.00K 10-K · filed 2021-03-29 | |||
| 2019-12-31 | $760.00K 10-K · filed 2021-03-29 | $919.00K 10-K · filed 2020-03-11 | ||
| 2019-03-31 | $233.00K 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | $1.02M 8-K · filed 2020-06-29 | $1.19M 10-K · filed 2020-03-11 | ||
| 2018-03-31 | $285.00K 10-Q · filed 2019-05-09 |